Teleflex (TFX) Stock Price
Teleflex Price
Teleflex (TFX) Stock | ISIN US8793691069 | WKN 855853. The current Teleflex stock price is 130.22 USD (2026). Revenue is 3.69 B USD. Net income is 682.34 M USD. The P/E ratio is 8.99. Market capitalization is 6.13 B USD. Teleflex operates in the Health sector.
Revenue has compounded at 3.6% per year over the past 19 years to 3.05 B USD. Earnings per share have declined at 4.3% per year over the last 19 years. Teleflex's net margin stands at 2.3%, down from 13.2% several years earlier. Teleflex currently offers a dividend yield of about 1.04%. The payout ratio is around 16% of earnings. The dividend has grown at 1.8% per year over the past 19 years.
Teleflex stock price
Details
Stock Price
ⓘHow to Read This Chart
This chart tracks the historical stock price of Teleflex over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.
Total Return vs. Price Return
The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.
Intraday Price Data
When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Teleflex stock reacts to market openings, earnings releases, or breaking news throughout the trading session.
What to Look For
Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Teleflex's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.
| Date | Teleflex Price |
|---|
Teleflex Revenue, EBIT, Net Income
3 Years
5 Years
10 Years
25 Years
Max
Details
Teleflex Income Statement, Balance Sheet, Cash Flow Statement
| REVENUE (B USD) |
|---|
| REVENUE GROWTH (%) |
| GROSS MARGIN (%) |
| GROSS INCOME (B USD) |
| NET INCOME (M USD) |
| NET INCOME GROWTH (%) |
| DIVIDEND (USD)DIV. (USD) |
| DIVIDEND GROWTH (%)DIV. GROWTH (%) |
| SHARES (M) |
| DOCUMENTS |
| 2023 | 2024 | 2025e | 2026e | 2027e | 2028e | 2029e | 2030e |
|---|---|---|---|---|---|---|---|
| 2.97 | 3.05 | 3.34 | 3.69 | 3.85 | 4.13 | 4.26 | 4.49 |
| 6.56 | 2.45 | 9.52 | 10.55 | 4.47 | 7.21 | 3.05 | 5.38 |
| 55.35 | 55.86 | 51 | 46.14 | 44.16 | 41.19 | 39.97 | 37.93 |
| 1.65 | 1.7 | 1.7 | 1.7 | 1.7 | 1.7 | 1.7 | 1.7 |
| 356 | 69 | 666 | 682 | 739 | 880 | 907 | 970 |
| -1.93 | -80.62 | 865.22 | 2.4 | 8.36 | 19.08 | 3.07 | 6.95 |
| 1.36 | 1.36 | 1.36 | 2.39 | 2.57 | - | - | - |
| – | – | – | 75.74 | 7.53 | – | – | – |
| 47.3 | 47.09 | 47.09 | 47.09 | 47.09 | 47.09 | 47.09 | 47.09 |
| – | – | – | – | – | – | – | – |
Details
Income Statement Key Figures
ⓘRevenue and Revenue Growth
Revenue is the starting point of every income statement — it measures the total sales Teleflex generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.
Gross Margin
Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Teleflex retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Teleflex's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.
EBIT and EBIT Margin
EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.
Net Income and Earnings Per Share (EPS)
Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.
Shares Outstanding
The total number of shares Teleflex has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.
Analyst Estimates
The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Teleflex's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.
Teleflex stock margins
3 Years
5 Years
10 Years
25 Years
Max
Details
Teleflex Stock Revenue, EBIT, Earnings per Share
3 Years
5 Years
10 Years
25 Years
Max
Details
Teleflex business model & stock analysis
Teleflex SWOT Analysis
Strengths
Teleflex Inc has established itself as a leading player in the medical technology industry, enjoying a strong market presence and a favorable brand reputation. This positions the company well to attract customers and gain a competitive edge over its rivals.
Teleflex Inc offers a wide range of medical devices and solutions, catering to various healthcare needs. This extensive product portfolio allows the company to target multiple market segments and diversify its revenue streams, reducing dependence on specific products or markets.
Weaknesses
Teleflex Inc's business is reliant on key customers and contracts, which exposes the company to potential risks if these customers reduce their orders or switch to competitors. This dependence can limit the company's flexibility in negotiating terms and pricing.
As a medical technology company, Teleflex Inc operates in a highly regulated industry. Adherence to strict regulations and potential changes in regulatory frameworks can create challenges for the company, impacting its product development and market access.
Opportunities
The global healthcare market is witnessing significant growth, driven by increasing healthcare expenditures and a rise in the aging population. Teleflex Inc can capitalize on this opportunity by expanding its product offerings and entering new markets, fueling revenue growth.
Rapid advancements in medical technology offer Teleflex Inc a chance to innovate and introduce new products or enhance existing ones. By staying at the forefront of technological developments, the company can attract customers seeking state-of-the-art medical devices and gain a competitive advantage.
Threats
Teleflex Inc operates in a highly competitive market with numerous global and regional players. The intense competition can impact pricing, market share, and profitability. The company needs to continuously innovate and differentiate itself to withstand competition effectively.
Teleflex Inc operates globally, which exposes it to currency exchange rate fluctuations. These fluctuations can affect the company's financial performance, as exchange rate movements impact revenue and profit margins when converting between currencies.
Teleflex Segments
Teleflex Revenue by Segment (1/3)
3 Years
5 Years
Max
Details
Teleflex Revenue by Segment (2/3)
Max
Details
Teleflex Revenue by Segment (3/3)
3 Years
5 Years
Max
Details
Teleflex Revenue by Region
3 Years
5 Years
Max
Details
Teleflex Eulerpool Fair Value
Teleflex historical P/E ratio, EBIT multiple, and P/S ratio
Teleflex annual returns
Details
Annual Return
ⓘWhat This Chart Shows
This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.
Price Return
Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.
Dividend Return
Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.
What to Look For
Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.
Teleflex shares outstanding
3 Years
5 Years
10 Years
25 Years
Max
Details
Teleflex Dividend History
36 years of dividend payments
Teleflex dividend history and estimates
3 Years
5 Years
10 Years
25 Years
Max
Details
Teleflex dividend payout ratio
3 Years
5 Years
10 Years
25 Years
Max
Details
Teleflex Earnings Estimates
Teleflex Earnings Estimates
| Date | EPS estimate | Revenue Estimate | Quarterly report |
|---|---|---|---|
| 4/30/2026 | 1.22USD | 538.59 MUSD | 2026 Q1 |
| 2/26/2026 | 3.77USD | 928.5 MUSD | 2025 Q4 |
| 2/19/2026 | 3.77USD | 928.5 MUSD | 2025 Q4 |
| 5/2/2024 | 3.17USD | 737.43 MUSD | 2024 Q1 |
| 2/21/2024 | 3.3USD | 776.38 MUSD | 2023 Q4 |
| 7/26/2023 | 3.43USD | 738.89 MUSD | 2023 Q2 |
| 4/26/2023 | 2.95USD | 672.38 MUSD | 2023 Q1 |
| 2/22/2023 | 3.48USD | 771.8 MUSD | 2022 Q4 |
| 10/27/2022 | 3.15USD | 701.86 MUSD | 2022 Q3 |
| 7/28/2022 | 3.38USD | 730.75 MUSD | 2022 Q2 |
EESG©
Eulerpool ESG Scorecard© for the Teleflex stock
EEnvironment
20
Environment
SSocial
20
Social
GGovernance (Corporate Governance)
4
Governance (Corporate Governance)
The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.
Teleflex shareholder structure
| % | Name |
|---|---|
12.62319% | |
10.55657% | |
10.18995% | |
8.81061% | |
5.10378% | |
3.11637% | |
3.09952% | |
2.63686% | |
2.59192% | |
2.09718% |
Teleflex Executives and Management Board
Mr. Liam Kelly
(58)Chairman of the Board, President, Chief Executive Officer · since 2012
Mr. Jay White
(51)Corporate Vice President and President, Global Commercial
Mr. James Winters
(52)Corporate Vice President - Manufacturing and Supply Chain
Mr. Daniel Logue
(51)Corporate Vice President, General Counsel and Secretary
Mr. Cameron Hicks
(60)Corporate Vice President - Human Resources and Communications
Teleflex Supply Chain
Frequently asked questions about Teleflex
Teleflex Inc is a leading global provider of medical technologies designed to enhance the health and well-being of patients. With a diverse product portfolio, the company specializes in the development, manufacturing, and distribution of innovative medical devices for a wide range of applications. Teleflex focuses on delivering high-quality solutions in critical care, surgical care, urology, and respiratory care, among others. By leveraging its expertise and strong market presence, Teleflex continuously aims to improve patient outcomes, increase healthcare efficiency, and advance medical innovation.
Teleflex stock
Teleflex Peer Group
Teleflex Ticker
Teleflex FIGI
All fundamentals and in-depth analysis of Teleflex
Our stock analysis for Teleflex Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Teleflex Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.